A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A23L 1/30 (2006.01) A61K 31/202 (2006.01) A61K 31/23 (2006.01)
Patent
CA 2322848
A method of treating disorders in which DHA levels are affected is described. The method includes administering to a subject suffering from the disorder a therapeutically effective amount of DHA. This method is particularly useful in treating subjects suffering from a disorder characterized by a defect in the CF gene, e.g., cystic fibrosis, or a chronic inflammatory disorder, e.g., ulcerative colitis, Crohn's disease, chronic pancreatitis, asthma, rheumatoid arthritis or chronic gastritis. A method of ameliorating affects of cystic fibrosis in a newborn and a method of increasing surfactant levels in a fetus are also described.
L'invention concerne un procédé relatif au traitement des troubles affectant les taux d'acide docasahexanoïque, qui consiste à administrer au patient une quantité thérapeutiquement efficace de cet acide. Le procédé est particulièrement utile pour le traitement des sujets souffrant d'un trouble caractérisé par une déficience du gène CF, à savoir par exemple : mucoviscidose, inflammation chronique du type colite ulcéreuse, maladie de Crohn, pancréatite chronique, asthme, polyarthrite rhumatoïde ou gastrite chronique. L'invention concerne également un procédé permettant de réduire les effets de la mucoviscidose chez le nouveau né, et un procédé qui permet d'augmenter les taux de tensioactif chez le foetus.
Alvarez Juan G.
Freedman Steven
Beth Israel Deaconess Medical Center
Riches Mckenzie & Herbert Llp
LandOfFree
Novel methods for treating disorders in which... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel methods for treating disorders in which..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel methods for treating disorders in which... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1832781